MS-271, a novel inhibitor of calmodulin-activated myosin light chain kinase from Streptomyces sp.—I. isolation, structural determination and biological properties of MS-271
- 1 January 1996
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 4 (1) , 115-120
- https://doi.org/10.1016/0968-0896(95)00175-1
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Siamycins I and II, New Anti-HIV Peptides. I. Fermentation, Isolation, Biological Activity and Initial Characterization.The Journal of Antibiotics, 1995
- Solution structure of RP 71955, a new 21 amino acid tricyclic peptide active against HIV-1 virusBiochemistry, 1994
- RES-701-1, a novel and selective endothelin type B receptor antagonist produced by Streptomyces sp. RE-701. II. Determination of the primary sequence.The Journal of Antibiotics, 1994
- MS-282a and MS-282b, new inhibitors of calmodulin-activated myosin light chain kinase from Streptomyces tauricus ATCC 27470.The Journal of Antibiotics, 1994
- Isolation of RP 71955, a new anti-HIV-1 peptide secondary metabolite.The Journal of Antibiotics, 1993
- MS-347a, a new inhibitor of myosin light chain kinase from Aspergillus sp. KY52178.The Journal of Antibiotics, 1993
- Anantin-A peptide antagonist of the atrial natriuretic factor(ANF). II. Determination of the primary sequence by NMR on the basis of proton assignments.The Journal of Antibiotics, 1991
- Kaempferol inhibits myosin light chain kinaseBiochemical and Biophysical Research Communications, 1989
- Thyroid hormones inhibit the Ca2+ calmodulin-induced activation of myosin light chain kinaseBiochemical and Biophysical Research Communications, 1988
- K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinasesBiochemical and Biophysical Research Communications, 1986